Cargando…

Ataxic Symptoms in Huntington’s Disease Transgenic Mouse Model Are Alleviated by Chlorzoxazone

Huntington’s disease (HD) is a hereditary neurodegenerative disease caused by a polyglutamine expansion in the huntingtin protein, Striatum atrophy in HD leads to a progressive disturbance of psychiatric, motor, and cognitive function. Recent studies of HD patients revealed that the degeneration of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Egorova, Polina A., Gavrilova, Aleksandra V., Bezprozvanny, Ilya B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147686/ https://www.ncbi.nlm.nih.gov/pubmed/32317916 http://dx.doi.org/10.3389/fnins.2020.00279

Ejemplares similares

A chlorzoxazone–folic acid combination improves cognitive affective decline in SCA2-58Q mice
por: Marinina, Ksenia S., et al.
Publicado: (2023)

Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
por: Chen, Xi, et al.
Publicado: (2011)

Green Constant-wavelength Concurrent Selective Fluorescence Method for Assay of Ibuprofen and Chlorzoxazone in Presence of Chlorzoxazone Degradation Product
por: Abdallah, Nora A., et al.
Publicado: (2023)

Evaluation of Dimebon in cellular model of Huntington's disease
por: Wu, Jun, et al.
Publicado: (2008)

Transient Developmental Purkinje Cell Axonal Torpedoes in Healthy and Ataxic Mouse Cerebellum
por: Ljungberg, Lovisa, et al.
Publicado: (2016)

A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation
por: Perez, Harvey, et al.
Publicado: (2021)

Dissolution enhancement of chlorzoxazone using cogrinding technique
por: Raval, Mihir K., et al.
Publicado: (2015)

Effects of Oral Rutaecarpine on the Pharmacokinetics of Intravenous Chlorzoxazone in Rats
por: Bista, Sudeep R., et al.
Publicado: (2008)

Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington's disease
por: Czeredys, Magdalena, et al.
Publicado: (2013)

Comparison of Sirtuin 3 Levels in ALS and Huntington’s Disease—Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models
por: Buck, Eva, et al.
Publicado: (2017)

Ataxic gait
por: Bhaskar, Shalini, et al.
Publicado: (2021)

Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease
por: Zhu, S, et al.
Publicado: (2011)

Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington disease
por: Faure, Alexis, et al.
Publicado: (2013)

Contribution of the Cerebellum to Predictive Motor Control and Its Evaluation in Ataxic Patients
por: Kakei, Shinji, et al.
Publicado: (2019)

Tetrabenazine is neuroprotective in Huntington's disease mice
por: Wang, Hongyu, et al.
Publicado: (2010)

Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model
por: Jiang, Wenxiao, et al.
Publicado: (2015)

Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
por: Henningsen, Jo B., et al.
Publicado: (2021)

Classification of Ataxic Gait
por: Vyšata, Oldřich, et al.
Publicado: (2021)

In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease
por: Callahan, Joshua W., et al.
Publicado: (2011)

Novel EAAT2 activators improve motor and cognitive impairment in a transgenic model of Huntington’s disease
por: Bhatnagar, Akanksha, et al.
Publicado: (2023)

Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington’s Disease
por: Chakroborty, Shreaya, et al.
Publicado: (2020)

Role of endoplasmic reticulum Ca2+ signaling in the pathogenesis of Alzheimer disease
por: Popugaeva, Elena, et al.
Publicado: (2013)

Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington's disease
por: Atherton, Jeremy F, et al.
Publicado: (2016)

Quantification of Huntington’s Disease Related Markers in the R6/2 Mouse Model
por: Etxeberria-Rekalde, Estibaliz, et al.
Publicado: (2021)

A novel and accurate full-length HTT mouse model for Huntington’s disease
por: Shenoy, Sushila A, et al.
Publicado: (2022)

Distinct histological alterations of cortical interneuron types in mouse models of Huntington’s disease
por: Voelkl, Kerstin, et al.
Publicado: (2022)

Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
por: Dickson, Elna, et al.
Publicado: (2022)

Ataxic Nystagmus in Disseminated Sclerosis
Publicado: (1944)

The weak and ataxic or paralyzed cat
por: Cuddon, Paul A
Publicado: (2006)

Amnesic and Ataxic Aphasia, Etc.
por: Cross, T. M. B.
Publicado: (1872)

Speech serial control in healthy speakers and speakers with hypokinetic or ataxic dysarthria: effects of sequence length and practice
por: Reilly, Kevin J., et al.
Publicado: (2013)

A quantitative framework for whole-body coordination reveals specific deficits in freely walking ataxic mice
por: Machado, Ana S, et al.
Publicado: (2015)

Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease
por: André, Véronique M., et al.
Publicado: (2011)

Commentary on “Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice”
por: Popugaeva, Elena, et al.
Publicado: (2014)

Dendritic Spines Shape Analysis—Classification or Clusterization? Perspective
por: Pchitskaya, Ekaterina, et al.
Publicado: (2020)

Circadian Abnormalities in Motor Activity in a BAC Transgenic Mouse Model of Huntington’s Disease
por: Oakeshott, Stephen, et al.
Publicado: (2011)

Genome-Wide Histone Acetylation Is Altered in a Transgenic Mouse Model of Huntington's Disease
por: McFarland, Karen N., et al.
Publicado: (2012)

Differential Alteration in Expression of Striatal GABA(A)R Subunits in Mouse Models of Huntington’s Disease
por: Du, Zhuowei, et al.
Publicado: (2017)

Enhanced GABAergic Inhibition of Cholinergic Interneurons in the zQ175(+/−) Mouse Model of Huntington's Disease
por: Lim, Sean Austin O., et al.
Publicado: (2021)

Pre-ataxic loss of intrinsic plasticity and motor learning in a mouse model of SCA1
por: Osório, Catarina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jlepaliggpul1sc11967o91b6b